In addition, the Rev-1 vaccine can induce serologic responses which interfere with diagnostic testing to detect infection by field strains of B. melitensis. Alternative control strategies, such as antibiotic treatment alone, or in combination with other methods, might be another approach to reducing the burden of brucellosis. The gene discussed is REV1; the disease is brucellosis.